DataMEDS AI, Inc. MEDS
Set alert
1.92 USD -0.11 -5.42%
At close · Oct 30
1.93 +0.01 +0.52%
After hours · Oct 30, 6:14 PM ET
1.86 Day range 1.98
0.851 52-week range 39.30
- YTD
- -90.40%
- 1 year
- -95.11%
- Open
- 1.94
- Prev close
- 2.03
- Mkt cap
- 9.95M
- Vol
- 146.47K
- Avg vol
- 6.52M
- EPS
- -46.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.86
- High
- 1.98
- Forward P/E
- -16.87
- Beta
- 0.00
- Short ratio
- 0.28
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Jul 18, 2024
- Earnings
- Aug 9, 2024
- 50-d avg
- 7.54
- 200-d avg
- 9.04
- 1y target
- 0.00
2Y chart
Events in this range
- May 26, 2026Split: 1 for 50
Signals (60)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| RSI: Overbought | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| RSI: Oversold | Aug 27, 2026 | 2 months ago |
| RSI: Oversold | Aug 24, 2026 | 2 months ago |
| RSI: Oversold | Aug 18, 2026 | 2 months ago |
| RSI: Oversold | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 5, 2026 | 4 months ago |
| MACD: Sell Signal | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 25, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 18, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 12, 2026 | 7 months ago |
| RSI: Oversold | Mar 12, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 11, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 5, 2026 | 8 months ago |
| RSI: Oversold | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 27, 2026 | 8 months ago |
| RSI: Oversold | Feb 26, 2026 | 8 months ago |
| RSI: Oversold | Feb 17, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 9 months ago |
| MACD: Buy Signal | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 8, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 17, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 24, 2025 | 1 year ago |
| RSI: Oversold | Oct 15, 2025 | 1 year ago |
| RSI: Oversold | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 16, 2025 | 1 year ago |
| RSI: Overbought | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 15, 2025 | 1 year ago |
| RSI: Oversold | Jul 8, 2025 | 1 year ago |
| RSI: Oversold | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 26, 2025 | 1 year ago |
| RSI: Oversold | Jun 18, 2025 | 1 year ago |
| RSI: Oversold | May 14, 2025 | 1 year ago |
| SMA: Bearish | May 8, 2025 | 1 year ago |
| MACD: Sell Signal | May 8, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 30, 2025 | 1 year ago |
Key statistics
- Market cap
- 13.28M
- Enterprise value
- 3.24M
- Trailing P/E
- 0.00
- Forward P/E
- -16.87
- PEG ratio
- 0.00
- Price / sales
- 1.78
- Price / book
- 0.91
- EPS (TTM)
- -24.38
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 56.68%
- Revenue (TTM)
- 7.45M
- Revenue growth
- -94.90%
- Free cash flow
- 0
- Total cash
- 7.72M
- Total debt
- 193.60K
- Return on equity
- 0.00%
- Shares outstanding
- 1.75M
- Short % of float
- 1.13%
- 50-day average
- 7.54
- 200-day average
- 9.04
Analyst view
Consensus: buy
Buy
Price target (mean) 0.00
Next earnings
Aug 9, 2024
Expected Aug 9, 2024. Consensus EPS estimate 0.00.
Financials — quick view
MEDS Revenue — quarterly 1.78M
MEDS Net income — quarterly -18.36M
MEDS EPS — quarterly -7.13
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 9, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jun 26, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Jan 16, 2024 | Sep 1, 2023 | 0.00 | — | — | — |
| May 15, 2023 | Mar 1, 2023 | -0.30 | — | — | — |
| Mar 27, 2023 | Dec 1, 2022 | -0.90 | — | — | — |
About DataMEDS AI, Inc.
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- trxadehealth.com
News
- DataMEDS AI Launches 'Health Lives Here' Community Respiratory Program To Be Marketed To 6,500+ Independent Pharmacies In Its Corexa Health Pharmacy Network
- DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
- Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
- DataMeds AI Signs LoI To Acquire Portion Of Quality Of Life Peace Of Mind IP Portfolio For Proprietary Position Until At Least 2042
- DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
- DataMeds AI Regains Compliance With Nasdaq Equity Rule
- DataMeds Regains Compliance With NASDAQ Listing Standards
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Contrasting Wellgistics Health (NASDAQ:MEDS) & Hims & Hers Health (NYSE:HIMS)
- DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Component
Your note
Sign in to keep a note on MEDS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AJJARAPU SURENDRA K | Chief Executive Officer | Stock Award(Grant) | Jan 4, 2024 | 0 |
| DOSS HOWARD A | Chief Financial Officer | Stock Award(Grant) | Apr 13, 2020 | 12,500 |
| FELL DONALD G. | Director | Stock Award(Grant) | Aug 31, 2022 | 75,664 |
| HUFFMAN JANET | Chief Financial Officer | Stock Award(Grant) | Dec 12, 2022 | 71,551 |
| JENNINGS CHRISTINE L. | Director | Stock Award(Grant) | May 26, 2021 | 10,912 |
| NEWELL A. JEFFREY | Director | Stock Award(Grant) | Dec 29, 2022 | 79,062 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Morgan Stanley | 1.11% | 13,867 | 180.96K | Jun 29, 2023 |
| Barclays Plc | 0.38% | 4,801 | 62.65K | Jun 29, 2023 |
| Tower Research Capital LLC (TRC) | 0.17% | 2,135 | 27.86K | Jun 29, 2023 |
| JP Morgan Chase & Company | 0.07% | 884 | 11.54K | Jun 29, 2023 |
| UBS Group AG | 0.07% | 900 | 11.74K | Jun 29, 2023 |
| Ronald Blue Trust, Inc. | 0.03% | 357 | 2.51K | Sep 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 1.94% | 24,189 | 101.59K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 1.23% | 15,392 | 64.65K | May 30, 2023 |
| Vanguard Extended Market Index Fund | 0.21% | 2,643 | 34.49K | Jun 29, 2023 |
| Fidelity Series Total Market Index Fund | 0.15% | 1,931 | 8.11K | May 30, 2023 |